Literature DB >> 19587038

Clearance of measles virus from persistently infected cells by short hairpin RNA.

Michael Zinke1, Sabine Kendl, Katrin Singethan, Markus Fehrholz, Dajana Reuter, Linda Rennick, Marco J Herold, Jürgen Schneider-Schaulies.   

Abstract

Subacute sclerosing panencephalitis (SSPE) is a demyelinating central nervous system disease caused by a persistent measles virus (MV) infection of neurons and glial cells. There is still no specific therapy available, and in spite of an intact innate and adaptive immune response, SSPE leads inevitably to death. In order to select effective antiviral short interfering RNAs (siRNAs), we established a plasmid-based test system expressing the mRNA of DsRed2 fused with mRNA sequences of single viral genes, to which certain siRNAs were directed. siRNA sequences were expressed as short hairpin RNA (shRNA) from a lentiviral vector additionally expressing enhanced green fluorescent protein (EGFP) as an indicator. Evaluation by flow cytometry of the dual-color system (DsRed and EGFP) allowed us to find optimal shRNA sequences. Using the most active shRNA constructs, we transduced persistently infected human NT2 cells expressing virus-encoded HcRed (piNT2-HcRed) as an indicator of infection. shRNA against N, P, and L mRNAs of MV led to a reduction of the infection below detectable levels in a high percentage of transduced piNT2-HcRed cells within 1 week. The fraction of virus-negative cells in these cultures was constant over at least 3 weeks posttransduction in the presence of a fusion-inhibiting peptide (Z-Phe-Phe-Gly), preventing the cell fusion of potentially cured cells with persistently infected cells. Transduced piNT2 cells that lost HcRed did not fuse with underlying Vero/hSLAM cells, indicating that these cells do not express viral proteins any more and are "cured." This demonstrates in tissue culture that NT2 cells persistently infected with MV can be cured by the transduction of lentiviral vectors mediating the long-lasting expression of anti-MV shRNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587038      PMCID: PMC2738273          DOI: 10.1128/JVI.00846-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  RNAi as a gene therapy approach.

Authors:  Natasha J Caplen
Journal:  Expert Opin Biol Ther       Date:  2003-07       Impact factor: 4.388

2.  Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.

Authors:  Daniel Boden; Oliver Pusch; Rebecca Silbermann; Fred Lee; Lynne Tucker; Bharat Ramratnam
Journal:  Nucleic Acids Res       Date:  2004-02-13       Impact factor: 16.971

Review 3.  RNA interference-based therapeutics: new strategies to fight infectious disease.

Authors:  M López-Fraga; N Wright; A Jiménez
Journal:  Infect Disord Drug Targets       Date:  2008-12

4.  Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell.

Authors:  R S Fujinami; M B Oldstone
Journal:  Nature       Date:  1979-06-07       Impact factor: 49.962

5.  Viral-mediated gene transfer to mouse primary neural progenitor cells.

Authors:  Stephanie M Hughes; Farid Moussavi-Harami; Sybille L Sauter; Beverly L Davidson
Journal:  Mol Ther       Date:  2002-01       Impact factor: 11.454

6.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.

Authors:  Douglas A Rubinson; Christopher P Dillon; Adam V Kwiatkowski; Claudia Sievers; Lili Yang; Johnny Kopinja; Dina L Rooney; Mingdi Zhang; Melanie M Ihrig; Michael T McManus; Frank B Gertler; Martin L Scott; Luk Van Parijs
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

7.  A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea.

Authors:  T Takasu; J M Mgone; C S Mgone; K Miki; K Komase; H Namae; Y Saito; Y Kokubun; T Nishimura; R Kawanishi; T Mizutani; T J Markus; J Kono; P G Asuo; M P Alpers
Journal:  Epidemiol Infect       Date:  2003-10       Impact factor: 2.451

8.  Antigenic characterization of measles and SSPE virus haemagglutinin by monoclonal antibodies.

Authors:  V ter Meulen; S Löffler; M J Carter; J R Stephenson
Journal:  J Gen Virol       Date:  1981-12       Impact factor: 3.891

9.  Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition.

Authors:  Atze T Das; Thijn R Brummelkamp; Ellen M Westerhout; Monique Vink; Mandy Madiredjo; René Bernards; Ben Berkhout
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors.

Authors:  Antonella Consiglio; Angela Gritti; Diego Dolcetta; Antonia Follenzi; Claudio Bordignon; Fred H Gage; Angelo Luigi Vescovi; Luigi Naldini
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-04       Impact factor: 11.205

View more
  9 in total

1.  APOBEC3G-Regulated Host Factors Interfere with Measles Virus Replication: Role of REDD1 and Mammalian TORC1 Inhibition.

Authors:  Vishakha Tiwarekar; Julia Wohlfahrt; Markus Fehrholz; Claus-Jürgen Scholz; Susanne Kneitz; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 2.  Measles virus infection of the CNS: human disease, animal models, and approaches to therapy.

Authors:  Dajana Reuter; Jürgen Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 4.148

Review 3.  Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus.

Authors:  Renata da Fontoura Budaszewski; Veronika von Messling
Journal:  Viruses       Date:  2016-10-11       Impact factor: 5.048

4.  KDELR2 Competes with Measles Virus Envelope Proteins for Cellular Chaperones Reducing Their Chaperone-Mediated Cell Surface Transport.

Authors:  Vishakha Tiwarekar; Markus Fehrholz; Jürgen Schneider-Schaulies
Journal:  Viruses       Date:  2019-01-04       Impact factor: 5.048

Review 5.  Measles Encephalitis: Towards New Therapeutics.

Authors:  Marion Ferren; Branka Horvat; Cyrille Mathieu
Journal:  Viruses       Date:  2019-11-02       Impact factor: 5.048

6.  A20 Is Increased in Fetal Lung in a Sheep LPS Model of Chorioamnionitis.

Authors:  Steffen Kunzmann; Matthias Hütten; Barbara Ottensmeier; Boris W Kramer; Markus Fehrholz
Journal:  Oxid Med Cell Longev       Date:  2022-01-20       Impact factor: 6.543

Review 7.  Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds.

Authors:  Katharina S Schmitz; Mona V Lange; Lennert Gommers; Kim Handrejk; Danielle P Porter; Christopher A Alabi; Anne Moscona; Matteo Porotto; Rory D de Vries; Rik L de Swart
Journal:  Viruses       Date:  2022-05-29       Impact factor: 5.818

8.  Caffeine and rolipram affect Smad signalling and TGF-β1 stimulated CTGF and transgelin expression in lung epithelial cells.

Authors:  Markus Fehrholz; Christian P Speer; Steffen Kunzmann
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

9.  Multi-targeted gene silencing strategies inhibit replication of Canine morbillivirus.

Authors:  Otávio Valério de Carvalho; Marcus Rebouças Santos; Juliana Lopes Rangel Fietto; Mauro Pires Moraes; Márcia Rogéria de Almeida; Gustavo Costa Bressan; Lindomar José Pena; Abelardo Silva-Júnior
Journal:  BMC Vet Res       Date:  2020-11-19       Impact factor: 2.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.